These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 12719775

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A role for the C2 domain of factor VIII in binding to von Willebrand factor.
    Saenko EL, Shima M, Rajalakshmi KJ, Scandella D.
    J Biol Chem; 1994 Apr 15; 269(15):11601-5. PubMed ID: 7512568
    [Abstract] [Full Text] [Related]

  • 7. Four hydrophobic amino acids of the factor VIII C2 domain are constituents of both the membrane-binding and von Willebrand factor-binding motifs.
    Gilbert GE, Kaufman RJ, Arena AA, Miao H, Pipe SW.
    J Biol Chem; 2002 Feb 22; 277(8):6374-81. PubMed ID: 11698391
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Antigenicity of putative phospholipid membrane-binding residues in factor VIII.
    Barrow RT, Healey JF, Jacquemin MG, Saint-Remy JM, Lollar P.
    Blood; 2001 Jan 01; 97(1):169-74. PubMed ID: 11133757
    [Abstract] [Full Text] [Related]

  • 11. A mechanism for inhibition of factor VIII binding to phospholipid by von Willebrand factor.
    Saenko EL, Scandella D.
    J Biol Chem; 1995 Jun 09; 270(23):13826-33. PubMed ID: 7775440
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Structural and functional characteristics of the B-domain-deleted recombinant factor VIII protein, r-VIII SQ.
    Sandberg H, Almstedt A, Brandt J, Gray E, Holmquist L, Oswaldsson U, Sebring S, Mikaelsson M.
    Thromb Haemost; 2001 Jan 09; 85(1):93-100. PubMed ID: 11204595
    [Abstract] [Full Text] [Related]

  • 14. Residues Glu2181-Val2243 contain a major determinant of the inhibitory epitope in the C2 domain of human factor VIII.
    Healey JF, Barrow RT, Tamim HM, Lubin IM, Shima M, Scandella D, Lollar P.
    Blood; 1998 Nov 15; 92(10):3701-9. PubMed ID: 9808564
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Factor VIII-von Willebrand factor binding defects in autosomal recessive von Willebrand disease type Normandy and in mild hemophilia A. New insights into factor VIII-von Willebrand factor interactions.
    Jacquemin M.
    Acta Haematol; 2009 Nov 15; 121(2-3):102-5. PubMed ID: 19506355
    [Abstract] [Full Text] [Related]

  • 20. Conservative mutations in the C2 domains of factor VIII and factor V alter phospholipid binding and cofactor activity.
    Gilbert GE, Novakovic VA, Kaufman RJ, Miao H, Pipe SW.
    Blood; 2012 Aug 30; 120(9):1923-32. PubMed ID: 22613792
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.